HLA and Sjögren's syndrome susceptibility. A meta-analysis of worldwide studies

Autoimmunity Reviews

Volumn 11, Issue 4, 2012, Pages 281-287

  Cruz Tapias, Paola ^a   Rojas Villarraga, Adriana ^a   Maier Moore, Shannon ^b,c   Anaya, Juan Manuel ^a,d  

^a UNIVERSIDAD DEL ROSARIO   (Colombia)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^d NONE   (Colombia)

Author keywords

HLA antigens; Meta analysis; Primary Sj gren's syndrome

Indexed keywords

AMINO ACID; HLA DR ANTIGEN; PEPTIDE;

ALLELE; ANTIGEN BINDING; AUTOIMMUNE DISEASE; CASE CONTROL STUDY; DATA BASE; DISEASE PREDISPOSITION; GENETIC ASSOCIATION; HLA SYSTEM; HLA TYPING; HUMAN; META ANALYSIS; REVIEW; RISK FACTOR; SJOEGREN SYNDROME; SYSTEMATIC REVIEW;

EID: 84857061990     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.10.002     Document Type: Review

References (52)

1. Anaya J.M., Mantilla R.D., Correa P.A. Immunogenetics of primary Sjögren's syndrome in Colombians. Semin Arthritis Rheum 2005, 34:735-743.
2. Anaya J.M., Tobon G.J., Vega P., Castiblanco J. Autoimmune disease aggregation in families with primary Sjögren's syndrome. J Rheumatol 2006, 33:2227-2234.
3. Wandstrat A., Wakeland E. The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nat Immunol 2001, 2:802-809.
4. Cobb B.L., Lessard C.J., Harley J.B., Moser K.L. Genes and Sjögren's syndrome. Rheum Dis Clin North Am 2008, 34:847-868.
5. Anaya J.M., Delgado-Vega A.M., Castiblanco J. Genetic basis of Sjögren's syndrome. How strong is the evidence?. Clin Dev Immunol 2006, 13:209-222.
6. Reveille J.D., Arnett F.C. The immunogenetics of Sjögren's syndrome. Rheum Dis Clin North Am 1992, 18:539-550.
7. Pérez P., Anaya J.M., Aguilera S., Urzúa U., Munroe D., Molina C., et al. Gene expression and chromosomal location for susceptibility to Sjögren's syndrome. J Autoimmun 2009, 33:99-108.
8. Reveille J.D., Macleod M.J., Whittington K., Arnett F.C. Specific amino acid residues in the second hypervariable region of HLA-DQA1 and DQB1 chain genes promote the Ro (SS-A)/La (SS-B) autoantibody responses. J Immunol 1991, 146:3871-3876.
9. Fye K.H., Terasaki P.I., Michalski J.P., Daniels T.E., Opelz G., Talal N. Relationship of HLA-Dw3 and HLA-B8 to Sjögren's syndrome. Arthritis Rheum 1978, 21:337-342.
10. Chused T.M., Kassan S.S., Opelz G., Moutsopoulos H.M., Terasaki P.I. Sjögren's syndrome association with HLA-Dw3. N Engl J Med 1977, 296:895-897.
11. Kang H.I., Fei H.M., Saito I., Sawada S., Chen S.L., Yi D., et al. Comparison of HLA class II genes in Caucasoid, Chinese, and Japanese patients with primary Sjögren's syndrome. J Immunol 1993, 150:3615-3623.
12. Kovács A., Endreffy E., Petri I., Kovács L., Pokorny G. HLA class II allele polymorphism in Hungarian patients with primary Sjögren's syndrome. Scand J Rheumatol 2006, 35:75-76.
13. *03 extended haplotype interaction in primary Sjögren's syndrome genetic susceptibility. Clin Exp Rheumatol 1998, 16:725-728.
14. Anaya J.M., Correa P.A., Mantilla R.D., Arcos-Burgos M. TAP, HLA-DQB1, and HLA-DRB1 polymorphism in Colombian patients with primary Sjögren's syndrome. Semin Arthritis Rheum 2002, 31:396-405.
15. Nakken B., Jonsson R., Brokstad K.A., Omholt K., Nerland A.H., Haga H.J., et al. Associations of MHC class II alleles in Norwegian primary Sjögren's syndrome patients: implications for development of autoantibodies to the Ro52 autoantigen. Scand J Immunol 2001, 54:428-433.
16. Morling N., Andersen V., Fugger L., Georgsen J., Halberg P., Oxholm P., et al. Immunogenetics of rheumatoid arthritis and primary Sjögren's syndrome: DNA polymorphism of HLA class II genes. Dis Markers 1991, 9:289-296.
17. Mori M., Yamada R., Kobayashi K., Kawaida R., Yamamoto K. Ethnic differences in allele frequency of autoimmune-disease-associated SNPs. J Hum Genet 2005, 50:264-266.
18. Roitberg-Tambur A., Friedmann A., Safirman C., Markitziu A., Ben-Chetrit E., Rubinow A., et al. Molecular analysis of HLA class II genes in primary Sjögren's syndrome. A study of Israeli Jewish and Greek non-Jewish patients. Hum Immunol 1993, 36:235-242.
19. García Portales R., Belmonte Lope M.A., Camps García M.T., Ocón Sánchez P., Alonso Ortiz A., Guil García M., et al. Immunogenetics of the Sjogren's syndrome in southern Spain. Ann Med Interna 1994, 11:56-61.
20. Fox R.I., Robinson C.A., Curd J.G., Kozin F., Howell F.V. Sjogren's Syndrome: proposed criteria for classification. Arthritis Rheum 1986, 29:577-585.
21. Skopouli F.N., Drosos A.A., Papaioannou T., Moutsopoulos H.M. Preliminary diagnostic criteria for Sjögren's syndrome. Scand J Rheumatol Suppl 1986, 61:22-25.
22. Manthorpe R., Oxholm P., Prause J.U., Schiødt M. The Copenhagen criteria for SjögrenD́s Syndrome. Scand J Rheumatol 1986, 61:19-21.
23. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-558.
24. Marsh S.G., Albert E.D., Bodmer W.F., Bontrop R.E., Dupont B., Erlich H.A., et al. Nomenclature for factors of the HLA system, 2010. Tissue Antigens 2010, 75:291-455.
25. Moher D., Liberati A., Tetzlaff J., Altman D.G. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009, 62:1006-1012.
26. Lee Y.H., Rho Y.H., Choi S.J., Ji J.D., Song G.G., Nath S.K., et al. The PTPN22 C1858T functional polymorphism and autoimmune diseases -a meta-analysis. Rheumatology 2007, 46:49-56.
27. Gottenberg J.E., Busson M., Loiseau P., Cohen-Solal J., Lepage V., Charron D., et al. In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Arthritis Rheum 2003, 48:2240-2245.
28. Bolstad A.I., Wassmuth R., Haga H.J., Jonsson R. HLA markers and clinical characteristics in Caucasians with primary Sjögren's syndrome. J Rheumatol 2001, 28:1554-1562.
29. Rischmueller M., Lester S., Chen Z., Champion G., Van Den Berg R., Beer R., et al. HLA class II phenotype controls diversification of the autoantibody response in primary Sjögren's syndrome (pSS). Clin Exp Immunol 1998, 111:365-371.
30. Wang J., Jiang M., Qiu C. Study on the relationship between primary Sjögren syndrome and HLA-DRbeta gene. Zhonghua Nei Ke Za Zhi 1997, 36:398-401.
31. Manthorpe R., Morling N., Platz P., Ryder L.P., Svejgaard A., Thomsen M. HLA-D antigen frequencies in Sjögren's syndrome. Differences between the primary and secondary form. Scand J Rheumatol 1981, 10:124-128.
32. Papasteriades C.A., Skopouli F.N., Drosos A.A., Andonopoulos A.P., Moutsopoulos H.M. HLA-alloantigen associations in Greek patients with Sjögren's syndrome. J Autoimmun 1988, 1:85-90.
33. Moriuchi J., Ichikawa Y., Takaya M., Shimizu H., Uchiyama M., Sato K., et al. Association between HLA and Sjögren's syndrome in Japanese patients. Arthritis Rheum 1986, 29:1518-1521.
34. Molina R., Provost T.T., Arnett F.C., Bias W.B., Hochberg M.C., Wilson R.W., et al. Primary Sjögren's syndrome in men. Clinical, serologic, and immunogenetic features. Am J Med 1986, 80:23-31.
35. Vitali C., Tavoni A., Rizzo G., Neri R., D'Ascanio A., Cristofani R., et al. HLA antigens in Italian patients with primary Sjögren's syndrome. Ann Rheum Dis 1986, 45:412-416.
36. Pease C.T., Shattles W., Charles P.J., Venables P.J., Maini R.N. Clinical, serological, and HLA phenotype subsets in Sjögren's syndrome. Clin Exp Rheumatol 1989, 7:185-190.
37. Julkunen H., Siren M.K., Kaaja R., Kurki P., Friman C., Koskimies S. Maternal HLA antigens and antibodies to SS-A/Ro and SS-B/La. Comparison with systemic lupus erythematosus and primary Sjögren's syndrome. Br J Rheumatol 1995, 34:901-907.
38. Panchovska M., Sheitanov Y., Martinova F. Locus DR in primary Sjögren's syndrome. Bratisl Lek Listy 2001, 102:382.
39. Manoussakis M.N., Georgopoulou C., Zintzaras E., Spyropoulou M., Stavropoulou A., Skopouli F.N., et al. Sjögren's syndrome associated with Systemic Lupus Erythematosus. Clinical and Laboratory Profiles and Comparison with pSS. Arthritis Rheum 2004, 5:882-891.
40. Harley J.B., Reichlin M., Arnett F.C., Alexander E.L., Bias W.B., Provost T.T. Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. Science 1986, 232:1145-1147.
41. Price P., Witt C., Allcock R., Sayer D., Garlepp M., Kok C.C., et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple munopathological diseases. Immmunol Rev 1999, 167:257-274.
42. Fridkis-Hareli M. Immunogenetic mechanisms for the coexistence of organ-specific and systemic autoimmune diseases. J Autoimmune Dis 2008, 5:1-9.
43. Castaño-Rodríguez N., Diaz-Gallo L.M., Pineda-Tamayo R., Rojas-Villarraga A., Anaya J.M. Meta-analysis of HLA-DRB1 and HLA-DQB1 polymorphisms in Latin American patients with systemic lupus erythematosus. Autoimmun Rev 2008, 7:322-330.
44. Mavragani C., Tzioufas A.G., Moutsopoulos H.M. Sjogren's Syndrome: autoantibodies to cellular Antigens. Int Arch Allergy Immunol 2000, 123:46-57.
45. Davies M.L., Taylor E.J., Gordon C., Young S.P., Welsh K., Bunce M., et al. Candidate T cell epitopes of the human La/SSB autoantigen. Arthritis Rheum 2002, 46:209-211.
46. *0201. Arthritis Rheum 2007, 56:3387-3398.
47. Kosmopoulou A., Vlassi M., Stavrakoudis A., Sakarellos C., Sakarellos-Daitsiotis M. T-cell epitopes of the La/SSB autoantigen: prediction based on the homology modeling of HLA-DQ2/DQ7 with the insulin-B peptide/HLA-DQ8 complex. J Comput Chem 2006, 27:1033-1144.
48. Paisansinsup T., Deshmukh U.S., Chowdhary V.R., Luthra H.S., Fu S.M., David C.S. HLA class II influences the immune response and antibody diversification to Ro60/Sjögren's syndrome-A: heightened antibody responses and epitope spreading in mice expressing HLA-DR molecules. J Immunol 2002, 168:5876-5884.
49. Routsias J.G., Tzioufas A.G. Sjögren's syndrome: study of autoantigens and autoantibodies. Clinic Rev Allerg Immunol 2007, 32:238-251.
50. Galperin C., Leung P.S., Gershwin M.E. Molecular biology of autoantigens in rheumatic diseases. Rheum Dis Clin North Am 1996, 22:175-210.
51. Witte T. Antifodrin antibodies in Sjögren's syndrome; a review. Ann NY Acad Sci 2005, 1051:235-239.
52. Gautam D., Duttaroy A., Cui Y., Han S.J., Deng C., Seeger T., et al. M1-M3 muscarinic acetylcholine receptor-deficient mice: novel phenotypes. J Mol Neurosci 2006, 30:157-160.